Results 1 to 10 of about 306,427 (234)

Heyde syndrome secondary to hypertrophic obstructive cardiomyopathy: a case report [PDF]

The Egyptian Heart Journal
Background Heyde syndrome is an uncommon clinical condition characterized by the triad of aortic stenosis, gastrointestinal angiodysplasia, and acquired von Willebrand syndrome.
Abraham Castellanos-Maldonado, Gustavo Abraham Canales-Azcona, José Luis Martínez-Arroyo, Miguel Maldonado-Valdéz, Héctor Raúl Ibarra-Sifuentes   +4 more
doaj   +2 more sources

Hereditary Transthyretin Cardiac Amyloidosis With Severe Left Ventricular Outflow Tract Obstruction Mimicking Hypertrophic Obstructive Cardiomyopathy [PDF]

JACC: Case Reports
Background: Cardiac amyloidosis may mimic hypertrophic cardiomyopathy; however, severe left ventricular outflow tract (LVOT) obstruction is rarely described in transthyretin (TTR) cardiac amyloidosis.
Batel Nissan, MD, Nur Magadale, MD, Vladimir Kaplinskiy, MD, Rabea Asleh, MD, PhD, Arthur Pollak, MD, Mordechai Golomb, MD   +5 more
doaj   +2 more sources

Mitral Transcatheter Edge-to-Edge Repair in Non-Surgical Candidates with Hypertrophic Obstructive Cardiomyopathy: Clip It, or Ablate It? [PDF]

Journal of Cardiovascular Development and Disease
Hypertrophic cardiomyopathy (HCM), with or without obstructive phenomena, remains underdiagnosed and undertreated. This condition often involves pathological changes in the mitral valve leaflets and apparatus, which can lead to relevant mitral ...
Emmanouil Chourdakis, Kambis Mashayekhi, Ulrich Schäfer, Christos Katsouras   +3 more
doaj   +2 more sources

Clinical Efficacy and Safety of Cox-Maze IV Procedure for Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy

Frontiers in Cardiovascular Medicine, 2021
Objective: Atrial fibrillation is the most prevalent persistent arrhythmia in patients with hypertrophic obstructive cardiomyopathy. Comparative analyses of the safety and effectiveness of septal myectomy with and without surgical ablation are limited ...
Yanhai Meng, Yanbo Zhang, Ping Liu, Changsheng Zhu, Tao Lu, Enci Hu, Qiulan Yang, Changrong Nie, Shuiyun Wang   +8 more
doaj   +1 more source

Periprocedural, Short-Term, and Long-Term Outcomes of Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A 20-Year Single-Center Experience

Anatolian Journal of Cardiology, 2022
Background: Alcohol septal ablation is recommended for hypertrophic obstructive cardiomyopathy patients who had refractory symptoms despite optimal medical treatment.
Umut Karabulut, Yeşim Yılmaz Can, Egemen Duygu, Dilay Karabulut, Kudret Keskin, Tuğrul Okay   +5 more
doaj   +1 more source

Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Information on impact of race and ethnicity on use and early outcomes of septal reduction therapies (SRTs) for obstructive hypertrophic obstructive cardiomyopathy are limited.
Sri Harsha Patlolla, Hartzell V. Schaff, Rick A. Nishimura, Mackram F. Eleid, Jeffrey B. Geske, Steve R. Ommen   +5 more
doaj   +1 more source

Neonatal hypertrophic cardiomyopathy with dyspnoea as the first symptom: a case report

Frontiers in Pediatrics, 2023
Neonatal hypertrophic cardiomyopathy (HCM) is an idiopathic disease characterised by myocardial hypertrophy with normal or small ventricular chambers, a systolic hyperdynamic state and diastolic dysfunction.
Xiaoxia Li, Shu-Jun Hong, Hui Hong, Zhi-Qun Zhang, Jing Li   +4 more
doaj   +1 more source

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes

Nature Communications, 2021
Progress in precision medicine is limited by insufficient knowledge of transcriptomic or proteomic features in involved tissues that define pathobiological differences between patients.
Bradley A. Maron, Rui-Sheng Wang, Sergei Shevtsov, Stavros G. Drakos, Elena Arons, Omar Wever-Pinzon, Gordon S. Huggins, Andriy O. Samokhin, William M. Oldham, Yasmine Aguib, Magdi H. Yacoub, Ethan J. Rowin, Barry J. Maron, Martin S. Maron, Joseph Loscalzo   +14 more
doaj   +1 more source

Mega Coronary Arteries with Obstructive Coronary Artery Disease in Hypertrophic Obstructive Cardiomyopathy: A Case Report and Literature Review

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2022
We report a rare case of hypertrophic obstructive cardiomyopathy (HOCM) presenting with mega coronary arteries with obstructive coronary artery disease.
Debasish Das, Debasis Acharya, Tutan Das, Subhas Pramanik   +3 more
doaj   +1 more source

Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathyCentral MessagePerspective

JTCVS Techniques, 2022
Objective: Some patients with obstructive hypertrophic cardiomyopathy may remain limited after surgical relief of the subaortic obstruction. In this report, we describe experience in surgical management of patients with advanced diastolic heart failure ...
Daokun Sun, MD, MPH, Hartzell V. Schaff, MD, Rick A. Nishimura, MD, Jeffrey B. Geske, MD, Joseph A. Dearani, MD, Steve R. Ommen, MD   +5 more
doaj   +1 more source